Open Access
REVIEW
The signaling pathway in modulating bone metabolism after dental implant in diabetes
Department of Oral Implantology, Affiliated Hospital of Chifeng University, Chifeng, 024000, China
* Corresponding Author: GUANGHUI LYU. Email:
BIOCELL 2021, 45(6), 1509-1519. https://doi.org/10.32604/biocell.2021.09506
Received 24 December 2019; Accepted 28 April 2020; Issue published 01 September 2021
Abstract
Diabetes Mellitus is a systematic disease with complications in multi-organs, including decreased implant osseointegration and a high failure rate of dental transplants. Accumulating evidence indicates that the signaling pathway directly impacts the process of bone metabolism and inflammatory response implicated with dental implants in diabetic patients. This review summarizes the recent advance in signaling pathways regulate osseointegration and inflammatory response in dental transplantation, aiming to identify the potential therapeutic target to reduce the dental transplant failure in diabetes patients, with emphasis on the surface characteristics of the implant, inflammatory signaling, AMPK, PPARγ, WNT, ROS, and adiponectin signaling.Keywords
Cite This Article
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.